Amarin Corp PLC (AMRN)
0.53
+0.01
(+0.97%)
USD |
NASDAQ |
Nov 22, 09:37
Amarin Debt to Equity Ratio: 0.00 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
September 30, 2024 | 0.00 |
June 30, 2024 | 0.00 |
March 31, 2024 | 0.00 |
December 31, 2023 | 0.00 |
September 30, 2023 | 0.00 |
June 30, 2023 | 0.00 |
March 31, 2023 | 0.00 |
December 31, 2022 | 0.00 |
September 30, 2022 | 0.00 |
June 30, 2022 | 0.00 |
March 31, 2022 | 0.00 |
December 31, 2021 | 0.00 |
September 30, 2021 | 0.00 |
June 30, 2021 | 0.00 |
March 31, 2021 | 0.00 |
December 31, 2020 | 0.00 |
September 30, 2020 | 0.0156 |
June 30, 2020 | 0.0373 |
March 31, 2020 | 0.0631 |
December 31, 2019 | 0.0824 |
September 30, 2019 | 0.1008 |
June 30, 2019 | 0.4602 |
March 31, 2019 | 0.5274 |
December 31, 2018 | 0.5275 |
September 30, 2018 | -2.147 |
Date | Value |
---|---|
June 30, 2018 | -2.507 |
March 31, 2018 | -7.151 |
December 31, 2017 | -1.884 |
September 30, 2017 | -2.709 |
June 30, 2017 | -3.288 |
March 31, 2017 | -4.464 |
December 31, 2016 | -12.86 |
September 30, 2016 | 7.735 |
June 30, 2016 | -1.500 |
March 31, 2016 | -1.559 |
December 31, 2015 | -1.905 |
September 30, 2015 | -2.080 |
June 30, 2015 | -2.524 |
March 31, 2015 | -3.678 |
December 31, 2014 | -2.565 |
September 30, 2014 | -3.227 |
June 30, 2014 | -4.159 |
March 31, 2014 | -4.268 |
December 31, 2013 | -7.384 |
September 30, 2013 | -13.55 |
June 30, 2013 | -2.510 |
March 31, 2013 | -3.981 |
December 31, 2012 | -58.54 |
September 30, 2012 | 3441.66 |
June 30, 2012 | 23.95 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Dec 2020
0.0824
Maximum
Dec 2019
0.0099
Average
--
Median
Dec 2020
Debt to Equity Ratio Benchmarks
Trinity Biotech PLC | -3.106 |
Adaptimmune Therapeutics PLC | 0.6234 |
Akari Therapeutics PLC | -- |
NuCana PLC | -- |
TC BioPharm (Holdings) PLC | -- |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 750.62M |
Total Liabilities (Quarterly) | 219.24M |
Shareholders Equity (Quarterly) | 531.38M |
Current Ratio | 3.226 |